| Original language | English |
|---|---|
| Pages (from-to) | 425-425 |
| Journal | Journal of Clinical Oncology |
| Volume | 31 |
| Issue number | 6_suppl |
| DOIs | |
| Publication status | Published - 20 Feb 2013 |
| Externally published | Yes |
Prognostic impact of baseline serum C-reactive protein in metastatic renal cell carcinoma treated with sunitinib.
Vano Yann-Alexandre, Benoit Beuselinck, Pascal Wolter, Corine Teghom, Debruyne Philip, Alexandra Karadimou, Evelyne Lerut, Paridaens Robert, Patrick Schöffski, Stephane Oudard
- Department of Medical Oncology, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, Paris-5 René Descartes University, Paris, France
- Medical Oncology Department, Georges Pompidou European Hospital, Paris, France; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Hopital Europeen Georges Pompidou, Paris, France; CHU de Tours, Tours, France; Alexandra Peripheral General Hospital, Athens, Greece; AZ Groeninge Hospital, Kortrijk, Belgium; IRCCS Policlinico San Matteo, Medicina Interna ed Oncologia Medica, Pavia, Italy; CHU de Bordeaux, Bordeaux, France; Georges Pompidou European Hospital, Paris, France
- HEGP, Oncology Department, Paris, France
- Inserm U674 Génomique Fonctionnelle des Tumeurs Solides, Université Paris-5 René Descartes, Paris, France
- Department of Pathology, University Hospitals Leuven, Leuven, Belgium
- Department of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
Research output: Contribution to journal › Article › peer-review
